Utah Medical Products, Inc.
UTMD
$56.25
$0.7651.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.30% | -14.37% | -25.74% | -19.99% | -19.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.30% | -14.37% | -25.74% | -19.99% | -19.17% |
| Cost of Revenue | 5.09% | -8.79% | -26.74% | -18.32% | -19.11% |
| Gross Profit | -10.52% | -18.15% | -25.01% | -21.16% | -19.20% |
| SG&A Expenses | 3.06% | 2.73% | -17.59% | -36.30% | -33.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.37% | -6.90% | -23.78% | -24.03% | -22.47% |
| Operating Income | -14.66% | -25.18% | -29.04% | -12.22% | -13.43% |
| Income Before Tax | -8.91% | -19.59% | -27.96% | -12.59% | -18.58% |
| Income Tax Expenses | 3.96% | -2.97% | -2.60% | -27.19% | -22.02% |
| Earnings from Continuing Operations | -11.73% | -23.13% | -32.29% | -9.45% | -17.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.73% | -23.13% | -32.29% | -9.45% | -17.79% |
| EBIT | -14.66% | -25.18% | -29.04% | -12.22% | -13.43% |
| EBITDA | -11.23% | -21.25% | -29.24% | -25.90% | -26.53% |
| EPS Basic | -3.97% | -15.98% | -27.41% | -5.52% | -15.54% |
| Normalized Basic EPS | -7.59% | -17.82% | -25.39% | -5.89% | -8.69% |
| EPS Diluted | -3.97% | -15.95% | -27.47% | -5.56% | -15.27% |
| Normalized Diluted EPS | -7.59% | -17.82% | -25.39% | -5.63% | -8.42% |
| Average Basic Shares Outstanding | -8.09% | -8.51% | -6.72% | -4.17% | -2.66% |
| Average Diluted Shares Outstanding | -8.09% | -8.51% | -6.72% | -4.42% | -2.94% |
| Dividend Per Share | 1.67% | 1.67% | 1.67% | 1.69% | 1.69% |
| Payout Ratio | 0.05% | 0.21% | 0.43% | 0.08% | 0.23% |